Sector: Health Care
Director information for BRISTOL MYERS SQUIBB (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Chris S. Boerner, PhD | CEO | 55 | ["Executive Leadership", "Healthcare", "Science/Technology/Innovation", "Financial", "Risk Management", "Sales & Marketing", "International"] | [] | 2026 |
| Christopher S. Boerner, Ph.D. | Director; Board Chair and Chief Executive Officer | [] | [] | 2026 | |
| Deepak L. Bhatt, MD | MPH, MBA | 58 | ["Executive Leadership", "Healthcare", "Science/Technology/Innovation", "Risk Management", "International", "Academia/Non-Profit", "Digital"] | [] | 2026 |
| Deepak L. Bhatt, M.D., M.P.H., M.B.A. | Director; Additional Member | [] | ["Audit Committee", "Committee on Directors and Corporate Governance", "Science and Technology Committee"] | 2026 | |
| Derica W. Rice | Director; Committee Chair | 61 | ["Healthcare", "Science/Technology/Innovation", "Financial", "Risk Management", "International"] | ["Audit Committee"] | 2026 |
| Julia A. Haller, M.D. | Director; Committee Member; Committee Chair | [] | ["Compensation and Management Development Committee", "Committee on Directors and Corporate Governance", "Science and Technology Committee"] | 2026 | |
| Julia A. Haller, MD | 71 | ["Executive Leadership", "Healthcare", "Science/Technology/Innovation", "Financial", "Risk Management", "International", "Academia/Non-Profit"] | [] | 2026 | |
| Karen H. Vousden, Ph.D. | Director; Additional Member | [] | ["Audit Committee", "Committee on Directors and Corporate Governance", "Science and Technology Committee"] | 2026 | |
| Karen H. Vousden, PhD | 68 | ["Healthcare", "Science/Technology/Innovation", "Financial", "Risk Management", "International", "Digital"] | [] | 2026 | |
| Manuel Hidalgo Medina, M.D., Ph.D. | Director; Committee Member; Additional Member | [] | ["Audit Committee", "Committee on Directors and Corporate Governance", "Science and Technology Committee"] | 2026 | |
| Manuel Hidalgo Medina, MD, PhD | 58 | ["Healthcare", "Science/Technology/Innovation", "Risk Management", "International", "Academia/Non-Profit"] | [] | 2026 | |
| Michael R. McMullen | Director; Additional Member | 65 | ["Healthcare", "Sales & Marketing", "International"] | ["Audit Committee", "Committee on Directors and Corporate Governance"] | 2026 |
| Paula A. Price | Director; Additional Member; Committee Member | 64 | ["Healthcare", "Science/Technology/Innovation", "Financial", "International"] | ["Audit Committee", "Compensation and Management Development Committee", "Committee on Directors and Corporate Governance"] | 2026 |
| Peter J. Arduini | Director | 61 | ["Executive Leadership", "Healthcare", "Science/Technology/Innovation", "Financial", "Risk Management", "Sales & Marketing", "International"] | [] | 2026 |
| Phyllis R. Yale | Director; Additional Member | 68 | ["Healthcare", "Science/Technology/Innovation", "Financial", "Risk Management", "International"] | ["Compensation and Management Development Committee", "Audit Committee", "Science and Technology Committee"] | 2026 |
| Samit Hirawat, M.D. | Former EVP and Chief Medical Officer, Head of Development | [] | [] | 2026 | |
| Scott Rosen | President and Chief Executive Officer | ["Chief Executive Officer at Bristol Myers Squibb (November 2023-present)", "Board Chair of Bristol Myers Squibb (April 2024-present)", "Board Member of Bristol Myers Squibb (2023-present)", "Executive Vice President, Chief Operating Officer at Bristol Myers Squibb (April 2023-October 2023)", "Executive Vice President, Chief Commercialization Officer at Bristol Myers Squibb (2018-2023)", "Head of International Markets at Bristol Myers Squibb (2017-2018)", "Head of U.S. Commercial Markets at Bristol Myers Squibb (2015-2017)", "Leadership roles at Seattle Genetics, Inc. (2010-2015)", "Marketing leadership roles at Genentech (2002-2010)", "Experience at McKinsey & Company with pharmaceutical and biotechnology clients", "President and Chief Executive Officer at GE Healthcare (2022-present)", "President and Chief Executive Officer at Integra LifeSciences Holdings Corporation (2012-2021)", "President and Chief Operating Officer at Integra LifeSciences Holdings Corporation (2010-2012)", "Corporate Vice President and President of Medication Delivery, Baxter Healthcare (2005-2010)", "15 years at General Electric Healthcare in various management roles"] | ["Compensation and Management Development Committee (Chair)"] | 2026 | |
| Theodore R. Samuels | LID; Director; Additional Member; Committee Chair | 71 | ["Executive Leadership", "Healthcare", "Science/Technology/Innovation", "Financial", "Risk Management", "International", "Academia/Non-Profit", "Digital"] | ["Compliance", "Compensation and Management Development Committee", "Audit Committee", "Committee on Directors and Corporate Governance"] | 2026 |
